Literature DB >> 21981728

Gammaretroviral vector integration occurs overwhelmingly within and near DNase hypersensitive sites.

Mingdong Liu1, Chang Long Li, George Stamatoyannopoulos, Michael O Dorschner, Richard Humbert, John A Stamatoyannopoulos, David W Emery.   

Abstract

Concerns surrounding the oncogenic potential of recombinant gammaretroviral vectors has spurred a great deal of interest in vector integration site (VIS) preferences. Although gammaretroviral vectors exhibit a modest preference for integration near transcription start sites (TSS) of active genes, such associations only account for about a third of all VIS. Previous studies suggested a correlation between gammaretroviral VIS and DNase hypersensitive sites (DHS), which mark chromatin regions associated with cis-regulatory elements. In order to study this issue directly, we assessed the correlation between 167 validated gammaretroviral VIS and a deep genome-wide map of DHS, both determined in the same cell line (the human fibrosarcoma HT1080). The DHS map was developed by sequencing individual DNase I cleavage sites using massively parallel sequencing technologies. These studies revealed an overwhelming preference for integrations associated with DHS, with a median distance of only 238 bp between individual VIS and the nearest DHS for the experimental dataset, compared to 3 kb for a random dataset and 577 to 1457 bp for two unrelated cell lines (p<0.001). Indeed, nearly 84% of all VIS were found to be located within 1 kb of a DHS (p=10(-43)). Further, this correlation was statistically independent from the association with TSS. The preference for DHS far exceeds that seen for other hallmarks of gammaretroviral VIS, including TSS, and may help explain several aspects of gammaretroviral vector biology, including the mechanism of VIS selection, as well as the relative frequency and underlying biology of gammaretroviral vector-mediated genotoxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21981728      PMCID: PMC3277727          DOI: 10.1089/hum.2010.177

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  33 in total

Review 1.  American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells.

Authors:  Donald B Kohn; Michel Sadelain; Cynthia Dunbar; David Bodine; Hans-Peter Kiem; Fabio Candotti; John Tisdale; Isabelle Riviére; C Anthony Blau; Robert E Richard; Brian Sorrentino; Jan Nolta; Harry Malech; Malcolm Brenner; Kenneth Cornetta; Joy Cavagnaro; Katherine High; Joseph Glorioso
Journal:  Mol Ther       Date:  2003-08       Impact factor: 11.454

2.  Mechanism of DNase I hypersensitive site formation within the human globin locus control region.

Authors:  C H Lowrey; D M Bodine; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

Review 3.  Nuclease hypersensitive sites in chromatin.

Authors:  D S Gross; W T Garrard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Characterization of a newly derived human sarcoma cell line (HT-1080).

Authors:  S Rasheed; W A Nelson-Rees; E M Toth; P Arnstein; M B Gardner
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

5.  Anatomy of hypersensitive sites.

Authors:  S C Elgin
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

6.  The 5' ends of Drosophila heat shock genes in chromatin are hypersensitive to DNase I.

Authors:  C Wu
Journal:  Nature       Date:  1980-08-28       Impact factor: 49.962

7.  Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites.

Authors:  H Rohdewohld; H Weiher; W Reik; R Jaenisch; M Breindl
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

8.  An enhancer/locus control region is not sufficient to open chromatin.

Authors:  M Reitman; E Lee; H Westphal; G Felsenfeld
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

9.  Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin.

Authors:  S Vijaya; D L Steffen; H L Robinson
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

10.  Nuclear scaffold attachment sites in the human globin gene complexes.

Authors:  A P Jarman; D R Higgs
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

View more
  4 in total

1.  Ectopic expression of HOXC6 blocks myeloid differentiation and predisposes to malignant transformation.

Authors:  Melanie Wurm; John Kowalski; Dirk Heckl; Xiao-Bing Zhang; Veronica Nelson; Brian C Beard; Hans-Peter Kiem
Journal:  Exp Hematol       Date:  2013-10-26       Impact factor: 3.084

2.  Evidence for the in vivo safety of insulated foamy viral vectors.

Authors:  D L Browning; E M Everson; D J Leap; J D Hocum; H Wang; G Stamatoyannopoulos; G D Trobridge
Journal:  Gene Ther       Date:  2016-12-26       Impact factor: 5.250

3.  MLV integration site selection is driven by strong enhancers and active promoters.

Authors:  Matthew C LaFave; Gaurav K Varshney; Derek E Gildea; Tyra G Wolfsberg; Andreas D Baxevanis; Shawn M Burgess
Journal:  Nucleic Acids Res       Date:  2014-01-23       Impact factor: 16.971

4.  A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance.

Authors:  Elizabeth M Everson; Miles E Olzsko; David J Leap; Jonah D Hocum; Grant D Trobridge
Journal:  Mol Ther Methods Clin Dev       Date:  2016-08-17       Impact factor: 6.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.